Applying John Neff's Low P/E method

u/raytoei · Reddit — r/ValueInvesting · 25 июля 2026, 15:01 · ⬆ 16 очк. · 💬 11 комментариев  | Открыть на Reddit ↗
AI-резюме
=== SUMMARY === - The author applies John Neff’s low P/E method (Total Return Ratio = EPS growth + dividend yield divided by P/E) to six medical technology stocks. - Only Boston Scientific (BSX) partially meets Neff’s criterion of a TRR greater than twice the S&P 500’s TRR, appearing borderline attractive on valuation. - The post is a methodological test of Neff’s framework rather than a strong conviction call; the author plans to monitor the approach going forward. **Quality assessment:** Well-researched DD – the author clearly explains the formula, sources data, and compares against market benchmarks. However, the conclusion is tentative and not a hard recommendation. === SENTIMENT === MIXED === TRADE IDEAS === BSX - WATCH | confidence: 0.60 | sentiment: +0.30 Speaker: u/raytoei Thesis: 1. THE FACT: BSX has a TRR (TTM) of 1.099, exceeding the 2× S&P TRR (TTM) threshold of 1.0736, and its FWD TRR of 1.188 is close to the 2× FWD threshold of 1.2794. 2. THE BRIDGE: This suggests BSX offers a favorable risk/reward under John Neff’s low-P/E framework, combining moderate growth (15.6% EPS CAGR) with no dividend, but a low forward P/E (~13.13). 3. THE VERDICT: The author flags BSX as the most attractive among the six names screened, but the edge is narrow and the stock has already moved up slightly, warranting monitoring rather than an immediate buy. 4. RISKS: Growth assumptions (15.6% EPS CAGR) may prove optimistic; the TRR ratio could fall below the 2× threshold if the stock price rises further or earnings disappoint; the method is backward-looking and may miss industry-specific risks. Timeframe: medium-term Key Points: - TRR TTM > 2x S&P threshold - Low forward P/E (~13.1) - High expected EPS growth (15.6%) - Borderline on FWD basis - Stock price already ticking up
Оценка 16
Комментарии 11
% апвоутов 100%
Полный текст поста
Идеи
u/raytoei Reddit r/ValueInvesting
BSX has a TRR (TTM) of 1.099, exceeding the 2× S&P TRR (TTM) threshold of 1.0736, and its FWD TRR of 1.188 is close to the 2× FWD threshold of 1.2794. This suggests BSX offers a favorable risk/reward under John Neff’s low-P/E framework, combining moderate growth (15.6% EPS CAGR) with no dividend, but a low forward P/E (~13.13). The author flags BSX as the most attractive among the six names screened, but the edge is narrow and the stock has already moved up slightly, warranting monitoring rather than an immediate buy. Growth assumptions (15.6% EPS CAGR) may prove optimistic; the TRR ratio could fall below the 2× threshold if the stock price rises further or earnings disappoint; the method is backward-looking and may miss industry-specific risks.
Ещё от Reddit — r/ValueInvesting

This Reddit post, published July 25, 2026, features u/raytoei discussing BSX. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/raytoei  · Tickers: BSX